A detailed history of Signaturefd, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 875 shares of RARE stock, worth $40,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
875
Previous 763 14.68%
Holding current value
$40,600
Previous $31,000 54.84%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$40.21 - $59.36 $4,503 - $6,648
112 Added 14.68%
875 $48,000
Q2 2024

Jul 29, 2024

BUY
$37.42 - $51.61 $898 - $1,238
24 Added 3.25%
763 $31,000
Q1 2024

May 03, 2024

BUY
$43.02 - $53.69 $2,667 - $3,328
62 Added 9.16%
739 $34,000
Q4 2023

Jan 31, 2024

SELL
$31.73 - $49.19 $7,615 - $11,805
-240 Reduced 26.17%
677 $32,000
Q3 2023

Nov 03, 2023

SELL
$34.92 - $46.66 $3,631 - $4,852
-104 Reduced 10.19%
917 $32,000
Q2 2023

Aug 01, 2023

BUY
$37.35 - $52.15 $11,391 - $15,905
305 Added 42.6%
1,021 $47,000
Q1 2023

Apr 28, 2023

SELL
$36.99 - $48.71 $27,594 - $36,337
-746 Reduced 51.03%
716 $28,000
Q4 2022

Jan 27, 2023

BUY
$33.72 - $46.33 $29,066 - $39,936
862 Added 143.67%
1,462 $67,000
Q3 2022

Nov 08, 2022

BUY
$39.96 - $66.14 $14,425 - $23,876
361 Added 151.05%
600 $25,000
Q2 2022

Aug 10, 2022

BUY
$45.8 - $85.4 $4,488 - $8,369
98 Added 69.5%
239 $14,000
Q1 2022

May 02, 2022

BUY
$62.2 - $84.4 $2,923 - $3,966
47 Added 50.0%
141 $10,000
Q4 2021

Jan 25, 2022

BUY
$73.71 - $87.86 $4,938 - $5,886
67 Added 248.15%
94 $8,000
Q3 2021

Oct 28, 2021

BUY
$77.92 - $102.4 $1,636 - $2,150
21 Added 350.0%
27 $2,000
Q2 2021

Jul 26, 2021

SELL
$92.19 - $115.71 $1,014 - $1,272
-11 Reduced 64.71%
6 $1,000
Q1 2021

Apr 30, 2021

SELL
$106.9 - $167.73 $534 - $838
-5 Reduced 22.73%
17 $2,000
Q4 2020

Feb 11, 2021

BUY
$84.4 - $177.39 $1,350 - $2,838
16 Added 266.67%
22 $3,000
Q3 2020

Nov 03, 2020

BUY
$72.98 - $90.0 $437 - $540
6 New
6 $0
Q4 2018

Feb 13, 2019

SELL
$38.89 - $77.3 $38 - $77
-1 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$44.33 - $58.52 $44 - $58
1 New
1 $0

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.25B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.